Loading…
Loading…
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies to Announce Second Quarter 2026 Financial Results and Host a Conference Call on July 30, 2026.
Investors interested in stocks from the Financial - Miscellaneous Services sector have probably already heard of Piper Sandler Companies (PIPR) and Moody's (MCO). But which of these two companies is the best option for those looking for undervalued stocks?
NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John D'Amico as a managing director in the Piper Sandler restructuring group. D'Amico will be focused on advising a broad range of clients in complex restructurings and special situation transactions.With approximately 25 years of investment banking and corporate advisory experience, D'Amico has advised companies, boards of directors, official and ad hoc creditor com.
On June 10, 2026, Piper Sandler Cos (PIPR) shares fell 3.3% today, closing at $76.53. The stock has fluctuated within a 52-week range of $62.49 to $95.07, showc
Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Orix (IX) and Piper Sandler Companies (PIPR). But which of these two stocks is more attractive to value investors?
Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic Participation by existing investors, including Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds Proceeds will support the conclusion of the STRIDE pivotal trial, continued operational scale-up, advancement of regulatory work toward a future Premarket Approval (PMA) submission to the FDA, and preparations for US commercialization Board strengthened with addition of Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representing Series C investors BOSTON, June 4, 2026 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced it has successfully completed the initial closing of an $85 million Series C financing. Piper Sandler Merchant Banking led the financing with participation from Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic, along with existing investors Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds.
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, has named Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Matt Sznewajs and John Tye, current co-heads of the services & industrials team, have been appointed vice chairmen of investment banking, and co-heads of private equity advisory. David Lee will join Sznewajs and Tye in leading the firm's private equity advisory effort while continuing to lead Piper S.
Wondering how high next year's Social Security benefit increase will be? Pay attention to the American consumer.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for PIPR and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.